Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force
Although the etiology of bipolar disorder remains uncertain, multiple studies examining
neuroimaging, peripheral markers and genetics have provided important insights into the …
neuroimaging, peripheral markers and genetics have provided important insights into the …
The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
G Morris, BK Puri, CC Bortolasci, A Carvalho… - Neuroscience & …, 2021 - Elsevier
Lowered high-density lipoprotein (HDL) cholesterol has been reported in major depressive
disorder, bipolar disorder, first episode of psychosis, and schizophrenia. HDL, its major …
disorder, bipolar disorder, first episode of psychosis, and schizophrenia. HDL, its major …
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
MK Chan, MG Gottschalk, F Haenisch, J Tomasik… - Progress in …, 2014 - Elsevier
Major psychiatric disorders such as schizophrenia, major depressive and bipolar disorders
are severe, chronic and debilitating, and are associated with high disease burden and …
are severe, chronic and debilitating, and are associated with high disease burden and …
Potential biomarkers for bipolar disorder: where do we stand?
R Sagar, RD Pattanayak - Indian Journal of Medical Research, 2017 - journals.lww.com
Bipolar disorder (BD) is a severe, recurrent mood disorder, associated with a significant
morbidity and mortality, with high rates of suicides and medical comorbidities. There is a …
morbidity and mortality, with high rates of suicides and medical comorbidities. There is a …
Systematic review and meta-analysis on MS-based proteomics applied to human peripheral fluids to assess potential biomarkers of bipolar disorder
JE Rodrigues, A Martinho, V Santos, C Santa… - International journal of …, 2022 - mdpi.com
Bipolar disorder (BD) is a clinically heterogeneous condition, presenting a complex
underlying etiopathogenesis that is not sufficiently characterized. Without molecular …
underlying etiopathogenesis that is not sufficiently characterized. Without molecular …
Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC–MS/MS and bioinformatics analysis
J Ren, G Zhao, X Sun, H Liu, P Jiang, J Chen… - …, 2017 - Elsevier
It is important to differentiate between bipolar disorder (BD) and major depressive disorder
(MDD) in the first depressive episode because of the potential treatment implications …
(MDD) in the first depressive episode because of the potential treatment implications …
From direct to indirect lithium targets: a comprehensive review of omics data
M Roux, A Dosseto - Metallomics, 2017 - academic.oup.com
Metal ions are critical to a wide range of biological processes. Among them, lithium (Li) has
been recognised for its benefit as a treatment for bipolar disorder (BD). However, we are yet …
been recognised for its benefit as a treatment for bipolar disorder (BD). However, we are yet …
[HTML][HTML] Depleting high-abundant and enriching low-abundant proteins in human serum: an evaluation of sample preparation methods using magnetic nanoparticle …
JR de Jesus, R da Silva Fernandes… - Talanta, 2017 - Elsevier
The efficiency of three different depletion methods to remove the most abundant proteins,
enriching those human serum proteins with low abundance is checked to make more …
enriching those human serum proteins with low abundance is checked to make more …
[HTML][HTML] Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder
YR Song, B Wu, YT Yang, J Chen, LJ Zhang… - Brazilian Journal of …, 2015 - SciELO Brasil
Bipolar disorder (BD) is a common psychiatric mood disorder affecting more than 1-2% of
the general population of different European countries. Unfortunately, there is no objective …
the general population of different European countries. Unfortunately, there is no objective …
A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients
EC Santa Cruz, F da Silva Zandonadi, W Fontes… - … et Biophysica Acta (BBA …, 2021 - Elsevier
A better understanding of the proteome profile after bipolar disorder (BD) and schizophrenia
(SCZ) treatment, besides monitoring disease progression, may assist on the development of …
(SCZ) treatment, besides monitoring disease progression, may assist on the development of …